Search clinical trials for: isolated systolic hypertension

Total 12193 results

Novartis

Completed

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

Hypertension

United States
Novartis

Completed

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

Hypertension

United States
Novartis Pharmaceuticals

Completed

Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans (ATLAAST)

Hypertension

United States
Novartis

Completed

Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus (ASTRIDE)

Hypertension | Diabetes Mellitus

United States
Second Affiliated Hospital of Nanchang University
Peking University First Hospital

Unknown

Feasibility Study of the Intensive Systolic Blood Pressure Control

Hypertension | Hyperhomocysteinemia

China
National Heart, Lung, and Blood Institute (NHLBI)
Williams LifeSkills

Completed

Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth

Cardiovascular Diseases | Hypertension

United States
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)

Completed

Systolic Hypertension in the Elderly Program (SHEP)

Heart Diseases | Cardiovascular Diseases | Cerebrovascular Disorders | Hypertension
Novartis Pharmaceuticals

Completed

An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

Systolic Hypertension

United States, Spain, Hungary, Korea, Republic of, Argentina, India, Slovakia, Canada, Romania
Northwell Health
GE Healthcare

Withdrawn

The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler Signals

Hypertension, Pulmonary

United States
Takeshi Morimoto

Terminated

Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound (PREVUS)

Coronary Artery Disease | Hypertension

Japan
University Medical Centre Ljubljana

Completed

Selective Vagus Nerve Stimulation in Human (VNS)

Ischemic Heart Disease | Arterial Hypertension

Slovenia
Monash University
Schering-Plough

Withdrawn

Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study (ACCESS)

Hypertension

Australia
Mount Sinai Hospital, Canada
Novo Nordisk A/S

Completed

Blood Pressure Outcomes With Liraglutide Therapy (BOLT)

Type 2 Diabetes | Systolic Hypertension

Canada
CAMC Health System

Completed

A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome

Insulin Resistance | Abdominal Obesity | Systolic Hypertension | Elevated Triglycerides

United States
Instituto Nacional de Cardiologia Ignacio Chavez
National Council of Science and Technology, Mexico

Completed

Hyperuricemia on Hypertension and Metabolic Syndrome

Systolic and Diastolic Blood Pressure Levels | Uric Acid Levels | Metabolic Syndrome Parameters | Hepatic Enzymes

Mexico
York University

Unknown

Improved Self Management in Uncontrolled Systolic Hypertension

Systolic Hypertension

Canada
Atlanta VA Medical Center
Emory University

Withdrawn

Vitamin D and Blood Pressure

Hypertension

United States
Wayne State University
Robert Wood Johnson Foundation

Completed

Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients

Hypertension | High Blood Pressure | Diastolic Dysfunction | Ventricular Hypertrophy | Systolic Dysfunction

United States
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)

Completed

Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)

Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Hypertension
Boehringer Ingelheim

Completed

A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)

Hypertension

Italy, Germany, Netherlands, France, South Africa, Belgium, Denmark, Finland, Ireland, Spain
Seoul National University Hospital

Completed

Prognostic Value of Early Postoperative Right Ventricular Systolic Function in Patients With Isolated Severe Tricuspid Regurgitation

Tricuspid Regurgitation

Korea, Republic of
Novartis

Completed

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus (ViVID)

Hypertension

United States
The Second Affiliated Hospital of Chongqing Medical...

Completed

Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AF

Atrial Fibrillation

China
Ricard Valero
Fundacion Clinic per a la Recerca Biomédica

Completed

Proseal Laryngeal Mask Airway or Endotracheal Tube for Emergence From Neuroanesthesia

Hypertension on Emergence

Spain
GE Healthcare
ICON Clinical Research

Completed

Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).

Pulmonary Hypertension

United States
Dairy Research Institute
BioFortis; Provident Clinical Research

Unknown

Clinical Trial to Assess the Effects of Low-fat Dairy on Systolic Blood Pressure

Hypertension

United States
Novartis

Completed

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension (AACESS)

Hypertension

United States
Novartis Pharmaceuticals

Completed

The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction

Hypertension | Diastolic Dysfunction

United States
Novartis

Completed

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients (ALIAS)

Essential Hypertension

France
Forest Laboratories

Completed

Nebivolol in Patients With Systolic Stage 2 Hypertension (NEB-MD-20)

Hypertension

United States
Novartis

Completed

Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal (ASSERTIVE)

Hypertension

Brazil, Canada, Ecuador, Germany, Hungary, Korea, Republic of, Malaysia, Mexico, Panama, Philippines, Singapore, Slovakia, Spain, Turkey, United Kingdom, Venezuela
Novartis

Completed

Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

Moderate to Severe Hypertension

Russian Federation, Romania, Singapore, Spain, Germany, Philippines
Novartis

Completed

Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise

Hypertension

Singapore, Hungary, Czech Republic, United Kingdom
Novartis

Completed

Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension (ASCENT)

Hypertension

United States
Novartis Pharmaceuticals

Completed

Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure

Hypertension

United States, Hungary, Poland, Turkey, Belgium, France, Germany, India, Italy, Slovakia, Sweden
Novartis Pharmaceuticals

Completed

Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure

Hypertension

Sweden, Belgium, Hungary, India, Italy, Poland, Turkey, United States, Brazil, France, South Africa
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Hypertension

United States
Novartis

Completed

Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older Population (ACTION)

Hypertension

United States
Novartis Pharmaceuticals

Completed

A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly

Hypertension

United States
Novartis

Completed

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension (ATTAIN)

Hypertension

United States
Novartis

Completed

Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension (AIMS)

Hypertension

United States
Novartis

Completed

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension (EXALT)

Stage 2 Systolic Hypertension

United States
Sunnybrook Health Sciences Centre
Heart and Stroke Foundation of Ontario

Completed

Conventional Versus Automated Measurement of Blood Pressure in the Office (The CAMBO Study) (CAMBO)

Hypertension

Canada
Takeda

Completed

Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

Hypertension
Synvista Therapeutics, Inc

Completed

The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)

Hypertension
Synvista Therapeutics, Inc

Terminated

Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)

Hypertension

United States
Medical University of Lodz

Unknown

Simvastatin in Patients With Isolated Arterial Hypertension (STIPPARE)

Hypertension

Poland
Synvista Therapeutics, Inc

Completed

The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling

Hypertension | Hypertrophy, Left Ventricular
Seoul National University Hospital

Unknown

Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients

Hypertension

Korea, Republic of
Ministry of Health, Labour and Welfare, Japan
Japan Cardiovascular Research Foundation

Unknown

Hypertension Control Based on Home Blood Pressure

Hypertension

Japan

3

Subscribe